Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis
Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis have?
Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis has 26 citations in the OpenAlex counts ScholarIQ stores.
When was Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis published?
Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis has 2024 year in the ScholarIQ index.
What is the open-access status of Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis?
Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis has bronze oa status in the ScholarIQ index.
What is the DOI of Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis?
The DOI for Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis is on the source record.
What is the PMID of Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis?
The PMID for Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis is on the source record.
What is the OpenAlex record for Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis?
The OpenAlex for Trends in management of patients with new‐onset refractory status epilepticus (<scp>NORSE</scp>) from 2016 to 2023: An interim analysis is on the source record.